JEFFREY HARRIS: Open Payments
NPI 1215134978 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 16 payments from 7 companies in 2025. Trend: 2023 $804 · 2024 $614 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 6 | $118 |
| ABBVIE INC. | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Tris Pharma Inc | 2 | $34 |
| Corium, LLC | 1 | $26 |
| Indivior Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Qelbree, VRAYLAR, CAPLYTA, Dyanavel XR, Azstarys, SUBLOCADE, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
